...
首页> 外文期刊>Canadian journal of surgery: Journal canadien de chirurgie >Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma.
【24h】

Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma.

机译:肝细胞癌患者中Foxp3 +调节性T细胞与门静脉肿瘤血栓的形成

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Most patients with hepatocellular carcinoma (HCC) have advanced-stage disease at diagnosis. The prognosis for patients with HCC is very poor, especially for those with portal vein tumour thrombi (PVTT). The purpose of our study was to observe the prognostic value of PVTT and tumour-infiltrating regulatory T cells (Tregs) and the correlation between them. METHODS: We examined 76 HCC specimens by immunohistochemistry for CD4+, CD8+ T cells and Foxp3+ Tregs. The survival of patients was prospectively followed up. Patients with HCC were grouped according to the formation of PVTT or Treg infiltration status. We performed a Kaplan-Meier survival analysis to observe the difference in prognosis between the groups. We analyzed the correlation of Treg expression with clinical and pathologic features. RESULTS: Survival analysis revealed that both the disease-free survival rate and total survival rate after hepatic resection were significantly lower in patients in the PVTT group than those in the non-PVTT group (p=0.026 and p=0.022, respectively). Likewise, both the disease-free survival rate and the total survival rate were significantly lower in patients in the high Treg group than those in the low Treg group (p=0.012 and p=0.023, respectively). We found that intratumoural Tregs were associated with PVTT formation (p=0.001) and that patients with high Treg infiltration had a higher percentage of PVTT formation. CONCLUSION: Patients with PVTT formation or high intratumoural Treg infiltration tended to have a poor prognosis. Intratumoural Treg was associated with formation of PVTT in patients with HCC.
机译:背景:大多数肝细胞癌(HCC)患者在诊断时患有晚期疾病。 HCC患者的预后非常差,尤其是门静脉肿瘤血栓(PVTT)患者。我们的研究目的是观察PVTT和肿瘤浸润调节性T细胞(Tregs)的预后价值及其之间的相关性。方法:我们通过免疫组织化学检查了76例HCC标本中的CD4 +,CD8 + T细胞和Foxp3 + Treg。前瞻性随访患者的生存情况。根据PVTT或Treg浸润状态的形成对HCC患者进行分组。我们进行了Kaplan-Meier生存分析,以观察各组之间预后的差异。我们分析了Treg表达与临床和病理特征的相关性。结果:生存分析显示,PVTT组患者的无病生存率和肝切除后总生存率均显着低于非PVTT组(分别为p = 0.026和p = 0.022)。同样,高Treg组患者的无病生存率和总生存率均显着低于低Treg组(分别为p = 0.012和p = 0.023)。我们发现肿瘤内Treg与PVTT形成相关(p = 0.001),并且高Treg浸润的患者具有更高的PVTT形成百分比。结论:PVTT形成或肿瘤内Treg高浸润的患者预后较差。肝癌患者肿瘤内Treg与PVTT的形成有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号